Seagen (SGEN) - Hot FDA News

Seagen (SGEN) – Hot FDA News

Sep 5, 2023 05:35 AM Seagen (SGEN) and Genmab (GMAB) Report TIVDAK Met its Primary Endpoint of Improved Overall Survival
Aug 16, 2023 08:00 AM Seagen (SGEN) Phase 3 Trial of TUKYSA with ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival
Jan 19, 2023 02:22 PM
Feb 3, 2022 08:03 AM
Sep 18, 2020 06:46 AM
Oct 21, 2019 06:46 AM
Jan 2, 2018 08:01 AM
Dec 11, 2017 05:50 AM
Dec 11, 2017 05:45 AM
Dec 11, 2017 05:39 AM
Dec 7, 2017 08:01 AM
Nov 10, 2017 07:18 AM
Oct 11, 2017 08:02 AM
Oct 10, 2017 08:06 AM
Oct 10, 2017 06:50 AM
Sep 11, 2017 06:24 AM
Aug 16, 2017 08:01 AM
Jul 25, 2017 08:05 AM
Jun 26, 2017 06:46 AM
Jun 20, 2017 08:03 AM
Jun 19, 2017 06:46 AM
Jun 15, 2017 07:00 AM
Jun 2, 2017 06:03 AM
Dec 27, 2016 08:00 AM
Jun 17, 2014 09:54 AM
Jun 25, 2013 07:07 AM
Aug 19, 2011 01:54 PM
Jul 14, 2011 11:32 AM
Dec 6, 2010 09:02 AM